Skip to the page

Data / Drug companies / Encube Ethicals, Inc.

Encube Ethicals, Inc.: 78 products in the FDA NDC directory, labeler code 21922

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Encube Ethicals, Inc. (labeler code 21922) lists 78 products in the FDA National Drug Code Directory, covering 55 finished drugs by generic name. By type: 67 prescription drugs, 11 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 1, 2026.

The request: Watch Encube Ethicals, Inc. (FDA labeler code 21922): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
21922
Products in commercial distribution
78
Packages
146
Finished drugs by generic name
55
Prescription products
67
Over the counter products
11
Controlled substance products
Schedule III 3
Flagged as original packager
75 of 75 products that carry the flag
Started marketing in the last 12 months
13
Earliest marketing start
March 4, 2019
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)6988.5%
Over the counter monograph drugs911.5%

Products by type

TypeProductsShare
Prescription drugs6785.9%
Over the counter drugs1114.1%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Gel2430.8%
Cream2126.9%
Ointment1823.1%
Solution911.5%
Lotion22.6%
Lotion, augmented11.3%
Shampoo11.3%
Kit11.3%
Suspension11.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Gentamicin sulfate21922-110OintmentGeneric drugs (ANDA)October 1, 2026
Econazole Nitrate21922-111CreamGeneric drugs (ANDA)July 1, 2026
Halobetasol Propionate21922-108OintmentGeneric drugs (ANDA)July 1, 2026
Hydrocortisone21922-065CreamGeneric drugs (ANDA)June 27, 2026
Lidocaine21922-107OintmentGeneric drugs (ANDA)June 20, 2026
Testosterone21922-109SolutionGeneric drugs (ANDA)June 19, 2026
Estradiol21922-015GelGeneric drugs (ANDA)May 13, 2026
Tretinoin21922-042GelGeneric drugs (ANDA)April 16, 2026
Mometasone furoate21922-071OintmentGeneric drugs (ANDA)April 7, 2026
Tretinoin21922-078CreamGeneric drugs (ANDA)March 26, 2026
Tretinoin21922-077CreamGeneric drugs (ANDA)February 13, 2026
Ciclopirox21922-105ShampooGeneric drugs (ANDA)December 3, 2025
Betamethasone Dipropionate21922-104Lotion, augmentedGeneric drugs (ANDA)November 25, 2025
Fluticasone Propionate21922-075CreamGeneric drugs (ANDA)October 18, 2025
Clindamycin and Benzoyl Peroxide21922-068KitGeneric drugs (ANDA)October 7, 2025
Estradiol vaginal21922-085CreamGeneric drugs (ANDA)August 14, 2025
Tretinoin21922-079CreamGeneric drugs (ANDA)July 11, 2025
Mupirocin21922-073OintmentGeneric drugs (ANDA)May 16, 2025
Nitroglycerin21922-054OintmentGeneric drugs (ANDA)April 16, 2025
Diclofenac sodium21922-033SolutionGeneric drugs (ANDA)April 14, 2025
Bacitracin zinc21922-091OintmentOver the counter monograph drugsMarch 13, 2025
Estradiol Gel21922-090GelGeneric drugs (ANDA)March 10, 2025
Estradiol Gel21922-089GelGeneric drugs (ANDA)March 10, 2025
Estradiol Gel21922-088GelGeneric drugs (ANDA)March 10, 2025
Estradiol Gel21922-087GelGeneric drugs (ANDA)March 10, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.